<DOC>
	<DOCNO>NCT02321475</DOCNO>
	<brief_summary>The purpose study determine effectiveness EGb 761® ( Tanakan® ) Russian patient middle age young , suffer psycho-emotional symptom add cognitive disorder base improvement FAM test ( feeling-healthy , activity , mood test ) score .</brief_summary>
	<brief_title>EGb 761® ( Tanakan® ) Effectiveness Treatment Patients Middle Age Younger With Psycho-emotional Symptoms , Added Cognitive Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Patients sign Informed Consent participation observational study collection information Patients complain psychoemotional disturbance ( intensity ) Men woman age 1845 year , prescribe receive Tanakan® cognitive disorder Presence contraindication list Tanakan® local SmPC ( hypersensitivity component Tanakan® , pregnancy , lactation , erosive gastritis acute phase , gastric ulcer duodenum ulcer acute phase , acute cerebrovascular accident , acute myocardial infarction , congenital galactosemia , lactase deficiency , glucosegalactose malabsorption , haemolysis ) Presence dementia ( accord Diagnostic Statistical Manual Mental Disorders [ DSM IV ] ) Disturbance usual activity daily live ( e.g . selfcare ) Patients take antipsychotic drug , antidepressant , tranquilliser nootropic agent Presence severe disease condition could affect cognitive function ( e.g . Parkinson disease , epilepsy , brain inflammatory disease , major depression , recent poststroke condition , recent braintrauma etc . ) ; Presence anxiety depression accord Hospital Anxiety Depression Scale ( 11 point ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Psycho-emotional symptom</keyword>
</DOC>